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Mice with inactivated TNF-LTce genes have profound abnormalities of the immune system with
hypoimmunoglobulinaemia, lack of lymph nodes, undifferentiated spleen, and defective Ig class
switch. Transplantation of bone marrow cells from wild-type mice restored the synthesis of TNF,
corrected the splenic microarchitecture, repopulated the lamina propria with IgA-producing
plasma cells, and normalized the serum immunoglobulin levels of TNF-LTce deficient mice.
Furthermore, the formation of germinal centers in the spleen and the defective Ig class switch in
response to a T-cell-dependent antigen is corrected. These data demonstrate that most TNF-
producing cells are bone-marrow-derived, and that the immunodeficiency due to TNF-LTce
deletion can be corrected to a large extent by normal bone marrow, cell transplantation.
Keywords: TNF-LTce knockout, immunodeficiency, bone marrow transplantation, germinal centers, Ig class
switch, alymphoplasia
INTRODUCTION
Tumor necrosis factor (TNF) and lymphotoxin ce
(LTce) are mediators of inflammation and immune
response (Aggarwal and Vilcek, 1992; Beutler, 1992).
Both ligands form homotrimers and bind to two
different receptors, tumor necrosis factor receptor
(TNFR- 1), and TNFR-2 (Loetscher et al., 1990;
Schall et al., 1990; Smith et al., 1993; Beutler and van
Huffel, 1994). The genetic inactivation of the TNFR-
1 (Pfeffer et al., 1993; Rothe et al., 1993) and TNFR-2
genes (Erickson et al., 1994) gave some indications
on the in vivo effects of TNF and LTce mediated
through these two receptor systems. Recently a third
ligand, LT/3, was identified that is expressed on the
cell membrane as a LTce/2LT/3 heterotrimer and binds
to the newly described LT/3-specific receptor (LT/3-
R) (Androlewicz et al., 1992; Baens et al., 1993;
Crowe et al., 1994; Force et al., 1995), suggesting a
novel function for the LTce/2LT/3 heterotrimer. This
pathway likely plays a role in the development of
secondary lymphoid organs since LTce-deficient mice
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lack lymph nodes (De Togni et al., 1994; Banks et al.,
1995).
We have generated a TNF-LTc-deficient mouse,
which has a complete disruption of the TNF-LTc
system, since it has neither of the two ligands
signaling through the TNFR-1 and -2 nor through the
LT/3-R (Eugster et al., 1996). These TNF-LTo
double-deficient mice develop normally with the
exception of a profound immunodeficiency. The
mutant mice have a sixfold increase of circulating B
lymphocytes, no peripheral lymphoid organs, an
undifferentiated spleen, a hypoimmunoglobulinemia,
and very few IgA-producing plasma cells in the
lamina propria of the small intestine.
Here, we asked to what extent the complex
phenotype of TNF-LTc deficiency is due to incompe-
tent lymphohemopoietic progenitors cells or rather
due to a defective environment. For this, we
attempted to restore the mutant phenotype by trans-
plantation of wild-type bone marrow cells.
RESULTS
The Cells Producing TNF Systemically On
Endotoxin Stimulation Are of Bone Marrow
Origin
TNF-LTc double-deficient mice fail to produce TNF
after endotoxin injection (Eugster et al., 1996). On
transplantation with wild-type bone marrow cells,
TNF-LTc-deficient mice respond to endotoxin with
TNF plasma levels at 1 h/z in the ng/ml range similar
to wild-type mice (Fig. 1A). TNF-LTc-deficient mice
lethally irradiated and reconstituted with TNF-LTc-
deficient bone marrow cells served as controls and
behaved essentially as nontransplanted TNF-LTo-
deficient mice. Conversely, lethally irradiated wild-
type mice produced high levels of TNF when
reconstituted with wild-type, but not with mutant
bone marrow cells. These results demonstrate that the
majority of cells producing TNF after endotoxin
stimulation are radiosensitive and bone-marrow-
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FIGURE Correction of TNF production in TNF-LTc (-/-)-deficient mice on bone marrow transplantation from wild-type mice: (A)
TNF plasma levels hr after LPS injection. (B) In vitro TNF production by bone marrow-derived macrophages stimulated with LPS (3hr,
10 ng/ml) in the presence of IFNy (100 U). Bone-marrow cells (2 106) from wild-type mice (+/+) or from TNF-LTc knockout (-/-)
donor mice were transplanted into lethally irradiated wild-type (+/+) or TNF-LTc knockout recipient mice (-/-). Analysis of the in vivo
TNF production in response to LPS (10 /xg i.p.) was performed 14 weeks posttransplantation, at a time point where the hematological
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derived. Ex vivo, bone-marrow-derived macrophages
from mutant mice reconstituted with wild-type donor
cells produced similar amounts of TNF on LPS
stimulation as those from wild-type controls (Figure
1B).
Correction of Splenic Follicles, IgA-Producing
Plasma Cell in the Lamina Propria and Serum
Ig Levels of TNF-LTa-Deficient Mice by Wild-
Type Bone Marrow Transplantation
The spleen of TNF-LTc-deficient mice are normal
sized, but show no organization of the white pulp
(Eugster et al., 1996). On transplantation of normal
bone marrow cells, the architecture of the follicles of
TNF-LTc-deficient mice is corrected with a distinct
separation of T- and B-cell areas (not shown) with
appearance of MAdCAM-1 expression in the mar-
ginal sinus endothelium (not shown). As expected,
mutant bone marrow was unable to correct the splenic
structure of TNF-LTo-deficient mice (data not
shown). Whereas the correction of the spleen was
successful, bone marrow transplantation did not
reconstitute peripheral lymph nodes in TNF-LTc-
deficient mice, indicating a developmental defect in
these mice.
TNF-LTc-deficient mice have a profound reduc-
tion of serum immunoglobulin level, especially of
IgA with an almost complete absence of IgA-
producing plasma cells in the intestine. Upon wild-
type marrow-cell transplantation, TNF-LTc-deficient
mice displayed a population of IgA-producing plasma
cells in the lamina propria that was indistinguishable
from that of wild-type controls (not shown). Since the
splenic structure and the production of IgA in the
lamina propria of the intestine were corrected by bone
marrow transplantation, we asked whether the hypoi-
munoglobinaemia was also normalized. In agreement
with previous studies, a profound reduction of Ig
isotypes in TNF-LTc-deficient mice was observed
(Eugster et al., 1996). Figure 2A shows a marked
reduction of IgG1 and almost complete absence of
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FIGURE 2 Serum IgG1 and IgA levels upon bone marrow reconstitution. (A) Wild-type control mice, (B) TNF-LTc knockout control
mice; (C) transplantation of wild-type or (D) TNF-LTo-/- bone marrow into TNF-LTo knockout mice (n 5 mice).256 B. RYFFEL et al.
IgA in nontransplanted mutant mice. Upon normal
bone marrow transplantation of TNF-LTc-deficient
mice, the IgG1 and IgA levels were increased
reaching levels of wild-type mice (Figure 2C), where
transplantation of mutant bone marrow did not correct
the hypoimmunoglobulinemia (Figure 2D).
Correction of Germinal Centers and
lmmunoglobulin Class Switch in TNF-LTce-
Deficient Mice by Wild-Type Bone Marrow
Transplantation
Since the splenic follicles were reconstituted by bone
marrow transplantation, we asked whether germinal
centers are induced on immunization with the thy-
mus-dependent antigen SRBC. Immunization induced
the formation of germinal centers in bone-marrow-
reconstituted TNF-LTce-deficient mice (Figure 3).
These secondary follicles displayed a distinct
immunoreactivity with FDC-M1 antibody typical for
follicular dendritic cells in germinal centers.
Furthermore, we tested whether the Ig class switch
defect described previously in TNF-LTce-deficient
mice (Eugster et al., 1996) was restored after bone
marrow transplantation. Upon transplantation of wild-
type bone marrow, TNF-LTce-deficient mice behaved
like the wild-type controls, namely, they responded to
SRBC by a transient synthesis of specific IgM
peaking at day 6 and decreasing at day 15 (Figure
4A). At this time point, the IgG response started, as
shown for IgG1, IgG2b, and IgG3 (Figs. 5B, 5C, and
5D). This was in contrast to the TNF-LTce-deficient
mice receiving mutant bone marrow, which showed
no IgG responses on day 15, but persistent IgM titres
on day 15 (Figs. 4A to 4D).
DISCUSSION
The present experiments demonstrate that bone mar-
row cells are able to correct the TNF-LTce deficiency.
Furthermore, the phenotype can be transferred into
normal mice by bone transplantation from TNF-LTce-
deficient mice (Muller et al., 1996). Therefore, the
genotype of the donor cells determines largely the
phenotype of the irradiated host. Furthermore, the
data suggest that the majority of cells producing TNF
and LTce are radiosensitive. Several previous studies
indicated that not only monocytes and T cells, but
many other cell types, for example, Kupffer cells and
hepatocytes, produce TNF and/or LTce (Aggarwal and
Vilcek, 1992; Hunt et al., 1992; Vassalli, 1992).
A
FIGURE 3 Induction of splenic germinal centers upon immunization in reconstitued TNF-LTce knockout mice by wild-type bone marrow
transplantation. (A) FDC-M1 reactive follicular dendritic cells after transplantation of wild-type bone marrow cells (2 10 cells) into
irradiated TNF/LTce knockout recipient mice. (B) By contrast, wild-type mice transplanted with mutant bone marrow cells show no FDC-M1
reactivity typical of germinal centersCORRECTION OF TNF-LTa PHENOTYPE BY BMT 257
Kupffer cells are in part bone-marrow-derived, but are
relatively radioresistant (Freudenberg et al., 1986).
Our results suggest that the nonbone-marrow-derived
cells apparently contribute little to the systemic
release of TNF in response to endotoxin.
Together with the reconstitution of TNF and LT
production, the splenic follicular structure was cor-
rected, the lamina propria of the intestines repopu-
lated by IgA-producing plasma cells, and the hypoim-
munoglobulinemia restored.
Repeated immunization with antigen did not induce
splenic germinal centers in TNF-LTa-deficient mice.
However, germinal centers were induced in TNF-
LTce-deficient mice reconstituted with normal bone
marrow cells. A similar reconstitution of germinal
centers by bone marrow cell transplantation was
reported in LTce-deficient mice (Matsumoto et al.,
1996a). Therefore, TNF or LTce are necessary for the
formation of germinal centers. Interestingly, TNF-R1-
deficient mice lack also a germinal center response,
suggesting that signaling through the type 1 TNF
receptor is necessary for this effect (Le Hir et al.,
1996; Matsumoto et al., 1996a). This finding is
supported by our previous observation that follicular
dendritic cells express high levels of TNF-R1 (Ryffel
et al., 1991).
500000
375000
o
"- 250000
<
125000
Donor
Recipient +/+
T
+/+ +/+ -/-
./. -/-
200000
C
T
150000
100000
50000.
Donor +/+ +/+
Recipient +/+ -/-
200000
150000
100000
r
50000.
Donor +/+ +/+ -/-
Recipient +/+ -/- -/-
40000
30000
20000
T
10000.
Donor +/+
Recipient +/+
./_ +/+ -/-
_/_ -/- -/-
FIGURE 4 Restoration of antigen-induced immunoglobulin class switch upon bone marrow transplantation into TNF-LTce-deficient mice.
The reconstituted mice were immunized with SRBC (2 108 i.p.) and the SRBC-specific (A) IgM, (B) IgG1, (C) IgG2b, and (D) IgG3 titers
were determined by ELISA prior to (solid bar) and 6 days (shaded bar) and 15 days (white bar) after immunization. Results are pooled from
(two) independent experiments and expressed as mean +_ SEM (n 7 to 8 mice per group).258 B. RYFFEL et al.
Although bone marrow transplantation from wild-
type mice was able to restore the immunodeficiency
of adult TNF-LTc-deficient mice to a large extent, no
lymph nodes were formed. Therefore, LTc is required
during the embryonic development of lymph nodes.
However, in the absence of TNF and LTc, the spleen
is formed although the microarchitecture is abnomal.
These findings indicate that the spleen and lymph
nodes have different requirements in embryonic
development. Since LTc-deficient mice (De Togni et
al., 1994; Banks et al., 1995) also lack lymph nodes,
but TNF-R-1 and -2 have normal lymph nodes
(Pfeffer et al., 1993; Rothe et al., 1993; Erickson et
al., 1994), the developmental pathways for lymph
nodes require LT/3-receptor signaling.
Several reports showed a possible involvement of
soluble and membrane-bound TNF in immuno-
globulin production. In particular, soluble TNF is able
to enhance the immune response to SRBC (Ghiara et
al., 1987). In addition it has been shown that TNF
expressed on the membrane of CD4 T cells, together
with the TNF-R1, participate in T-B cell interactions,
resulting in enhanced immunoglobulin production
(Aversa et al., 1993; Del-Prete et al., 1994).
Our data unequivocally demonstrate that TNF and/
or LTc play a role in Ig class switching. Since no
defect in the Ig class switch has been observed in
TNF-R-1 and -2 deficient mice (Pfeffer et al., 1993;
Rothe et al., 1993; Erickson et al., 1994), we propose
that it is the signal from the LTo//3 heteromer through
the LT/3-R that is necessary for isotype switching. Of
note is also the finding that the defective Ig class
switch was corrected by bone-marrow transplantation.
Finally, germinal centers might not be necessary since
a normal Ig class switch and affinity maturation was
reported in LTc-deficient mice on immunization at a
high protein dose (Matsumoto et al., 1996a).
In conclusion, transplantation of normal bone
marrow into TNF-LTo mutant mice allowed func-
tional and to some extent morphological correction of
the immune defect seen in the TNF-LTo-deficient
mice. Conversely, the mutant phenotype could be
transferred by bone marrow cells transplanted into
wild-type recipient mice.
MATERIALS AND METHODS
Mice
TNF-LTc knockout mice were generated as described
on a mixed genetic 129/Ev/Sv C57BL/6 back-
ground (Eugster et al., 1996). Seven- to ten-week-old
wild-type and knockout mice bred in our animal
facility and maintained under specific pathogen-free
conditions were utilized.
Reagents
Antibodies used in flow cytometry and FACS analysis
were rat anti-mouse monoclonal antibodies (mAb)
F4/80, B220, and CD3 (ATTC, Rockville, MD) and
FDC-M1 (M. Kosco-Vilbois, Glaxo, Geneva). Anti-
rat globulin goat IgG coupled to Cy-3 (Milan
Analytica, LaRoche, Switzerland) or to phycoerythrin
(Sigma, St. Louis) were used as a secondary antibody.
Biotin-conjugated affinity-purified goat anti-mouse
IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA (Southern
Biotechnology Associates, Birmingham, AL), and
alkaline phophatase (AP)-coupled streptavidin (Jack-
son Immunoresearch Laboratories, West Grove, PA)
were used in ELISA.
Bone-Marrow Transplantation
Recipient mice received a lethal total-body irradiation
(determined as 7.0 Gy in the knockout and wild-type
mice), prior to the intravenous injection of 2 106
fresh, unseparated bone marrow cells.
Injection of Endotoxin
Mice were injected intraperitoneally with 10 #g of
LPS (E. coli, serotype O111 :B4, Sigma, St. Louis) in
saline solution (0.9%). Blood was taken at h/z after
LPS injection and plasma was analyzed for TNF
levels. Blood samples were obtained from the tail
vein, the retroorbital sinus, or cardiac puncture at
euthanasia. Plasma concentrations of TNF were
determined by a cytotoxicity assay using the WEHI-
164 clone 13 cells (Espevik and Nissen-Meyer,
1986).CORRECTION OF TNF-LTce PHENOTYPE BY BMT 259
Stimulation of Macrophages
Bone-marrow-derived macrophages were isolated
from femurs and cultivated (106/ml) for 7 days in
Dulbecco’s minimal essential medium (DMEM) sup-
plemented with 20% horse serum and 30% L929 cell-
conditioned medium (as source of M-CSF). After 7
days culture, the cell preparation contains 99%
macrophages (Kelso et al., 1982). The bone-marrow-
derived macrophages were stimulated with LPS (10
ng/ml) for 3 h/z and the supernatant was assesssed for
TNF activity as described.
Anti-SRBC Serum Isotype and Ig Levels
Mice were immunized with 2 l0 SRBC i.v. and
serum was collected before and at 3, 6, 9, and 15 days
postimmunization. Serum levels of anti-SRBC-spe-
cifi Ig levels for IgM, IgG1, Ig2a, Ig2b, IgG3, and
IgA were determined by a sandwich ELISA. Max-
isorp microtiter plates were coated overnight with 50
/1 of a solubilized extract (3 /g/ml) from SRBC
prepared according to (Kelly et al. 1979). Thereafter,
plates were blocked with 2% BSA containing PBS for
2 h/z at 37C, and serial dilutions of the immune sera
were incubated overnight at room temperature. Bound
antibodies were detected with biotinylated goat anti-
mouse Ig-isotype-specific antibodies (4 h/z at room
temperature). Subsequently, streptavidin-conjugated
to alkaline phosphatase and substrate were added for
45 min each, and the reaction was stopped with 1.5 M
NaOH. Absorbance was read at 405 nm in a Titertek
Multiskan spectrophotometer (Flow Laboratories).
Serum titers are expressed as the reciprocal value of
the dilution showing an optical density of 0.1 over
background.
lmmunofluorescence Staining of Tissues
Tissues were snap frozen in supercooled (liquid
nitrogen) isopentane and stored at -80C, as pre-
viously described (Ryffel et al., 1991). Routinely
prepared frozen sections were cut at 5/zm and fixed
in acetone for 10 min, blocked in wash solution (50
mM Tris/HC1, 150 mM NaC1) for 30 min, and then
incubated overnught at 4C with rat anti-mouse mAb
specific for CD3, B220, and FDC-M1. Controls,
including incubation with secondary antibody alone,
were uniformly negative. After two washes, sections
were incubated with goat--anti-rat antibody labeled
with Cy-3 at room temperature for h/z. After a final
wash, the slides were mounted in a Shandon Immuno-
mount and coverslipped. Immunostained sections
were examined with a Laser Scan Microscope 320
(Carl Zeiss, Zirich) in a confocal mode with a
excitation wavelength of 543
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